Awareness and Inclusion of Neurodiversity in the Healthcare Systems of Five Arab Countries: A Scoping Review

Journal of the History of Biology · Springer Nature · 2026-11-05 · DOI: 10.1007/s10803-026-07582-z

Аннотация

Background Despite growing global attention to neurodiversity, evidence on awareness, inclusion, and policy development within Arab healthcare systems remains limited and fragmented. This scoping review mapped progress and gaps in how Saudi Arabia, Qatar, the UAE, Oman, and Jordan—three being high-income countries—address neurodiversity within their healthcare systems. Methods The review followed PRISMA-ScR guidelines. PubMed/MEDLINE, Arab World Research Source, Scopus, and Web of Science were systematically searched, supplemented by structured grey literature searches in English and Arabic through October 2025. Eligible studies addressed neurodiversity or neurodevelopmental conditions, including ASD, ADHD, intellectual disability, and learning disorders, within healthcare contexts and reported outcomes related to awareness, policy, service access, or inclusion. Two reviewers independently screened studies and extracted data using standardized methods. Findings were narratively synthesized by theme. Study quality was assessed using appropriate JBI Critical Appraisal Checklists, and grey literature using AACODS. Results Thirty-two peer-reviewed studies met the inclusion criteria, with most published between 2019 and 2025. Saudi Arabia contributed 10 studies, followed by Oman (6), Qatar (5), Jordan (4), and the UAE (3), alongside four multi-country or regional studies. Neurodiversity-related policies remained largely autism-specific. Qatar’s National Autism Plan (2017) and Saudi Arabia’s national autism program represented the most formalized initiatives; however, post-diagnostic intervention uptake remained approximately 5% in Qatar’s large-scale screening program. Provider knowledge was generally low to moderate, with competency scores below threshold in Saudi Arabia and primary-care knowledge gaps documented in Oman and Jordan. Access barriers included diagnostic delays, geographical constraints, and cost. In Saudi Arabia, 44.1% of guardians experienced delays obtaining an initial diagnosis; in Qatar, 75% of patients waited up to one year for the first intervention visit; and 58% of patients in Jordan identified cost as an access barrier. Telehealth showed potential in the UAE and Oman, including a UAE model that reduced waiting times from 7.1 to 1.3 weeks. Standardized clinical guidelines, national registries, and transition-to-adult-care services were largely absent or unreported. Conclusion Progress in neurodiversity inclusion remains uneven. Saudi Arabia, Qatar, and the UAE demonstrate greater development of policies, screening initiatives, and telehealth, whereas Oman and Jordan show limited neurodiversity-specific policy development and greater reliance on broader disability frameworks. Major gaps persist in policy, workforce capacity, and service delivery. Unified guidelines, workforce training, cross-sector integration, and culturally grounded strategies involving community and religious leaders are needed to reduce disparities and strengthen neurodiversity-inclusive care.

Читать у издателя →

Похожие статьи